South Korea Intravenous (IV) Equipments Market Overview, 2031

South Korea has an aging population, with a significant proportion of elderly citizens. This demographic trend could influence the demand for healthcare services, including intravenous therapies. IV equipment tailored for geriatric care, such as infusion pumps with specific features for elderly patients, may be a focus in the market. The increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, contributes to the demand for IV therapies. IV equipment designed for the effective and safe administration of medications for chronic diseases may see notable market growth. Cultural factors can play a role in healthcare decisions. Understanding patient preferences and cultural considerations may impact the design and features of IV equipment to ensure they align with the expectations and comfort levels of patients in South Korea. South Korea, being prone to natural disasters like earthquakes, places a high value on emergency preparedness in the healthcare sector. IV equipment that is durable, portable, and suitable for emergency situations may have a specific market niche. Collaboration between IV equipment manufacturers and the pharmaceutical industry is essential. Aligning product development with the latest pharmaceutical trends, such as the formulation of new intravenous medications, can be a strategic approach for companies in the South Korean market. Compliance with international certification standards, such as CE marking, is crucial for companies looking to export IV equipment globally. South Korean manufacturers may prioritize obtaining certifications to enhance the marketability of their products internationally. The IV equipment market in South Korea may witness a demand for devices tailored to specific therapeutic needs.
According to the research report, "South Korea Intravenous Equipment Market Overview, 2031," published by Bonafide Research, the South Korea Intravenous Equipment market is expected to reach a market size of more than 410 Million by 2031.The incorporation of smart technologies into IV equipment, allowing for connectivity and real-time data monitoring, may be a trend. Smart pumps with features such as dose tracking, alert systems, and wireless communication could gain prominence. Advancements in needle-free IV administration technology could be a notable trend, offering solutions that reduce needle-related complications, improve patient comfort, and enhance the overall safety of intravenous therapies. Wearable devices designed for IV administration, such as wearable infusion pumps or devices for continuous monitoring of patient vitals during intravenous therapy, may become more prevalent in the market. Development of mobile applications that empower patients to manage and track their IV treatments may gain prominence. These apps could provide real-time information, reminders, and communication channels with healthcare providers. Advances in biopharmaceuticals and personalized medicine may influence trends in IV equipment. The administration of complex biologic therapies might drive the need for specialized IV delivery systems. Improvements in alarm systems and safety features in IV equipment could be a trend. This might include smarter alerts, automated safety protocols, and user-friendly interfaces to minimize the risk of errors during infusion. Specialized IV equipment designed for pediatric patients may become a noticeable trend. Child-friendly designs, precise dosing capabilities, and features catering to the unique needs of pediatric care could see increased attention.

In the South Korea intravenous equipment market, the product hierarchy reflects a blend of everyday essentials and advanced clinical technologies tailored to the country’s modernized healthcare ecosystem. IV catheters are the most dominant and widely used product type, forming the backbone of IV therapy across hospitals, clinics, and outpatient environments due to their indispensable role in establishing vascular access for fluids, medications, and nutrients. Peripheral catheters generate the largest revenue share in this segment because they are suited for routine use in fluid administration, emergency care, and surgical procedures, while central venous catheters are emerging as the fastest growing sub category as demand increases for long term therapies and critical care applications. IV infusion pumps constitute another key product category, ranking high in technological sophistication and value contribution. The South Korea infusion pumps market is expanding steadily, with volumetric pumps leading in revenue due to their widespread adoption for precise and controlled delivery of drugs and fluids in intensive care units, oncology departments, and surgical suites. Insulin infusion pumps, meanwhile, are among the fastest growing segments as chronic disease prevalence rises and demand for automated, patient centric solutions grows. Beyond catheters and pumps, IV administration sets and solutions remain essential consumables that facilitate sterile fluid transfer and drive recurring replacement demand. IV securement devices, stopcocks, and check valves play important roles in stabilizing catheter setups and managing fluid flow during complex procedures, while others such as speciality connectors and drip chambers support niche clinical needs.

Hospitals and clinics, including dialysis centers, stand as the most significant application segment, accounting for the vast majority of IV equipment utilization nationwide. These institutional environments manage high patient throughput and deliver critical services such as emergency treatment, surgical care, intensive therapies, and chronic disease management, all of which depend heavily on IV devices like catheters, infusion pumps, and administration sets. Dialysis centers, a vital subset within this segment, contribute consistently to demand due to the repetitive and long duration nature of renal therapies that require reliable vascular access and precise fluid control. The prominence of hospitals and clinics reflects South Korea’s comprehensive healthcare infrastructure and its commitment to maintaining high standards of patient safety and clinical efficiency. Ambulatory surgical centers (ASCs) are an emerging application area in South Korea, particularly as outpatient and same day procedures become increasingly common. In these settings, IV equipment is used for anesthesia infusions, perioperative fluid support, and short term postoperative care, with a preference for efficient, compact, and easy to operate systems that facilitate quick patient turnover. While ASCs currently represent a smaller share compared to hospitals, their growth signals shifting care delivery models that prioritize decentralization and cost effective procedures. Home care settings are also gaining traction as a growing application segment, driven by demographic trends such as an aging population and a rising incidence of chronic conditions that require ongoing IV therapies.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Intravenous Equipments Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation



By Product Type
• IV Catheters
• IV Infusion Pumps
• IV Securement Devices
• IV Administration Sets & Solutions
• IV Needles & Syringes
• Stopcocks & Check Valves
• Others

By Application
• Hospitals & Clinics/Dialysis Centers
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others